Open AccessImpact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy
Author(s) -
Chiara Lazzari,
Vanesa Gregorc,
Mariacarmela Santarpía
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.10.67
Subject(s) - osimertinib , epidermal growth factor receptor , medicine , lung cancer , epidermal growth factor , oncology , cancer research , lung , receptor , pathology , erlotinib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom